
Chemotherapy
StormscaleUS<Is So Cute>

StormscaleUS<Is So Cute>
Updated Jul 02, 2026, 15:12 UTC · 2 days ago · data from the Blizzard Battle.net API
Retribution Paladin · Build 1 import string
Retribution Paladin · Build 2 import string
Retribution Paladin · Build 3 import string
Protection Paladin · Build 1 import string
Protection Paladin · Build 2 import string
Protection Paladin · Build 3 import string
Protection Paladin · Build 4 import string
Gear: 285 item level · 8/8 enchants · 4/4 gems — see full loadout, enchants & gems.
| Bracket | Rating | Rank | W–L | Games | Win% |
|---|---|---|---|---|---|
| 2331 | #1009 | 135–112 | 247 | 55% | |
| 1749 | #2153 | 20–16 | 36 | 56% |
Drag to rotateSecondary stats as the character was last geared & logged out.
| Battleground | Played | W–L | Win% |
|---|---|---|---|
| Deepwind Gorge | 14 | 9–5 | 64% |
| Twin Peaks | 13 | 6–7 | 46% |
| Temple of Kotmogu | 13 | 6–7 | 46% |
| Arathi Basin | 13 | 8–5 | 62% |
| Isle of Conquest | 12 | 8–4 | 67% |
| Battleground | Played | W–L | Win% |
|---|---|---|---|
| Rated Eye of the Storm | 12 | 6–6 | 50% |
| Warsong Gulch | 12 | 9–3 | 75% |
| Eye of the Storm | 10 | 6–4 | 60% |
| The Battle for Gilneas | 10 | 3–7 | 30% |
| Battle for Wintergrasp | 10 | 3–7 | 30% |
| Silvershard Mines | 9 | 4–5 | 44% |
| Ashran | 8 | 3–5 | 38% |
| Seething Shore | 8 | 3–5 | 38% |
| Alterac Valley | 6 | 3–3 | 50% |
| Deephaul Ravine | 3 | 2–1 | 67% |
| Slayer's Rise | 2 | 2–0 | 100% |
| Arathi Basin Winter | 1 | 1–0 | 100% |
| Dungeon | Key | Time | Date |
|---|---|---|---|
| Skyreach | +13 | 25:13 ★ | — |
| Seat of the Triumvirate | +13 | 27:27 ★ | — |
| Maisara Caverns | +12 | 23:45 ★ | — |
| Algeth'ar Academy | +12 | 26:55 ★ | — |
| Windrunner Spire | +12 | 28:43 ★ | — |
| Nexus-Point Xenas | +12 | 23:46 ★ | — |
| Magisters' Terrace | +11 | 25:23 ★ | — |
| Pit of Saron | +10 | 18:52 ★ | — |
| Nexus-Point Xenas | +8 | 32:58 ✕ | — |
| Skyreach | +7 | 31:45 ✕ | — |
18,880 achievement points · honor level 242 · ranked in 2 brackets · <Is So Cute>
See every mount Chemotherapy has collected - loaded live from the armory. Click below to pull the current collection straight from Blizzard.
See every battle pet Chemotherapy has collected - loaded live from the armory. Click below to pull the current collection straight from Blizzard.
Chemotherapy peaks at 2331 rating (Duelist) in Solo Shuffle - Retribution Paladin, and is ranked across 2 rated brackets this season on Stormscale (US).
Yes — Chemotherapy carries a Mythic+ rating of 2937 alongside their rated PvP this season.
Chemotherapy's highest-rated Solo Shuffle spec is Retribution Paladin at 2331 rating (Duelist).
Chemotherapy wins 55% of their Solo Shuffle - Retribution Paladin games this season (135–112).
Chemotherapy is a Human Retribution Paladin on Stormscale (US) who has pushed into Duelist territory, ranked across 2 rated brackets. Their best result is 2331 rating (Duelist) in Solo Shuffle - Retribution Paladin — the top 20% of Solo Shuffle - Retribution Paladin this season.
Chemotherapy plays Retribution Paladin as their ranked specialisation, carrying a 16-slot loadout running 16 epic pieces, 8 enchanted and 4 gems socketed and a notably lean item level of 285 for that rating. On the profession side they have trained Skinning, Enchanting, Cooking and Fishing. Their current talent build is available to copy below, or open it in our interactive talent calculator.
Chemotherapy has played 283 rated games this season. Their ratings span a wide 582-point range between brackets, so the bulk of that effort is concentrated in their strongest format. Their best current placements are #1009 in Solo Shuffle - Retribution Paladin (2331), #2153 in Battleground Blitz - Retribution Paladin (1749).
This is not a PvP-only character: Chemotherapy carries a Mythic+ rating of 2937 and 81 earned titles. Full gear, talents, battleground win rates and PvE progression are broken down below; you can also see how they place on our Mythic+ leaderboards and PvP ladders.
View Chemotherapy on the official WoW Armory →
Profile data as of Jul 01, 2026.